We are live on ! Find out more
RHJA

Rice Hall James & Associates Portfolio holdings

AUM $2.05B
1-Year Est. Return 43.16%
This Fund
S&P 500
This Quarter Est. Return
-0.31%
1 Year Est. Return
+43.16%
3 Year Est. Return
+139.79%
5 Year Est. Return
+169.96%
10 Year Est. Return
+906.29%
AUM
$2.71B
AUM Growth
-$105M
Cap. Flow
-$29.7M
Cap. Flow %
-1.1%
Top 10 Hldgs %
23.72%
Holding
332
New
19
Increased
70
Reduced
176
Closed
23

Sector Composition

Rank Sector Weight
1 Technology 25.75%
2 Healthcare 24.54%
3 Industrials 15.71%
4 Consumer Discretionary 13.79%
5 Communication Services 6.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XYL icon
151
Xylem
XYL
$28.1B
$2.84M 0.11%
22,987
-818
-3% -$105K
YMAB
152
DELISTED
Y-mAbs Therapeutics
YMAB
$2.83M 0.1%
99,291
+2,517
+3% +$79.3K
KRNT icon
153
Kornit Digital
KRNT
$791M
$2.81M 0.1%
19,403
-185
-0.9% -$24.4K
OPTN
154
DELISTED
OptiNose
OPTN
$2.8M 0.1%
62,140
+388
+0.6% +$16.3K
LOCO icon
155
El Pollo Loco
LOCO
$462M
$2.79M 0.1%
165,305
-576
-0.3% -$10.4K
UFPT icon
156
UFP Technologies
UFPT
$2.43B
$2.74M 0.1%
44,522
-67
-0.2% -$4.23K
ESTA icon
157
Establishment Labs
ESTA
$2.28B
$2.72M 0.1%
37,948
+52
+0.1% +$3.83K
NEO icon
158
NeoGenomics
NEO
$2.13B
$2.69M 0.1%
55,669
-658
-1% -$30.5K
TVTX icon
159
Travere Therapeutics
TVTX
$5.78B
$2.65M 0.1%
109,206
+2,379
+2% +$43.7K
HLIT icon
160
Harmonic Inc
HLIT
$1.28B
$2.64M 0.1%
301,540
+3,026
+1% +$27.1K
AXGN icon
161
Axogen
AXGN
$2.5B
$2.61M 0.1%
165,082
+63,829
+63% +$1.15M
PRIM icon
162
Primoris Services
PRIM
$4.45B
$2.58M 0.1%
105,358
-1,323
-1% -$35.5K
VPG icon
163
Vishay Precision Group
VPG
$914M
$2.57M 0.1%
73,985
-346
-0.5% -$12.6K
CBZ icon
164
CBIZ
CBZ
$2.96B
$2.54M 0.09%
78,584
-2,447
-3% -$79.6K
SHYF
165
DELISTED
The Shyft Group
SHYF
$2.54M 0.09%
66,778
-15,229
-19% -$617K
THRY icon
166
Thryv Holdings
THRY
$108M
$2.54M 0.09%
84,448
-37
-0% -$1.16K
NPTN
167
DELISTED
NEOPHOTONICS CORP
NPTN
$2.52M 0.09%
289,838
+138,802
+92% +$1.27M
CSCO icon
168
Cisco
CSCO
$479B
$2.52M 0.09%
46,289
-1,842
-4% -$103K
ERII icon
169
Energy Recovery
ERII
$443M
$2.51M 0.09%
132,097
-703
-0.5% -$14.3K
URGN icon
170
UroGen Pharma
URGN
$2.29B
$2.51M 0.09%
149,260
-92,377
-38% -$1.46M
CW icon
171
Curtiss-Wright
CW
$25.5B
$2.5M 0.09%
19,823
+5,282
+36% +$631K
ALNT icon
172
Allient
ALNT
$1.92B
$2.49M 0.09%
79,735
+261
+0.3% +$8.54K
ATRS
173
DELISTED
Antares Pharma, Inc.
ATRS
$2.46M 0.09%
676,687
-1,996
-0.3% -$8.07K
JOUT icon
174
Johnson Outdoors
JOUT
$505M
$2.45M 0.09%
23,190
-82
-0.4% -$9.36K
DVN icon
175
Devon Energy
DVN
$47.3B
$2.43M 0.09%
68,520
-1,637
-2% -$46.4K

Similar funds

Rice Hall James & Associates's Q3 2021 Portfolio in Review

As of Q3 2021, Rice Hall James & Associates held 332 positions worth $2.71B, down 3.7% from $2.81B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Rice Hall James & Associates's Q3 2021 filing shows 19 new, 70 increased, 176 reduced and 23 closed positions. Its largest new stake was GXO Logistics: 305,297 shares worth $23.9M. The largest sale was XPO, an estimated $20.8M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Healthcare and Industrials.

  • Rice Hall James & Associates's largest Q3 2021 buy was GXO Logistics: 305,297 shares worth $23.9M.
  • Rice Hall James & Associates added most to Bed Bath & Beyond in Q3 2021, an estimated $7.08M increase.
  • Rice Hall James & Associates's biggest Q3 2021 reduction was XPO, cutting an estimated $20.8M.
  • Rice Hall James & Associates fully exited Nektar Therapeutics in Q3 2021, selling an estimated $8.49M.
  • Rice Hall James & Associates's ten largest holdings make up 24% of its $2.71B portfolio in Q3 2021.
  • Rice Hall James & Associates opened 19 new positions and closed 23 in Q3 2021.
  • Rice Hall James & Associates's portfolio value fell 3.7% quarter-over-quarter to $2.71B.

Based on Rice Hall James & Associates's 13F filing for Q3 2021, filed 9 Nov 2021.